CHROMADEX CORP
CHROMADEX CORP
Aktie · US1710774076 · CDXC · A2AG5N (XNCM)
Übersicht
Analyst Grade Summary
gauge-img
Kaufen
Starker Kauf
Kaufen
Halten
Verkaufen
Starker Verkauf
0
6
2
0
0
Kein Kurs
28.10.2025 20:29
Aktuelle Kurse von CHROMADEX CORP
BörseTickerWährungLetzter UmsatzKursTagesveränderung
XNAS: NASDAQ
NASDAQ
NAGE
USD
28.10.2025 20:29
7,27 USD
-0,33 USD
-4,34 %
Free Float & Liquidität
Free Float 65,39 %
Shares Float 50,84 M
Ausstehende Aktien 77,75 M
Firmenprofil zu CHROMADEX CORP Aktie
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers, as well as to distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient NIAGEN; NIAGEN as an active ingredient in its consumer products under the TRU NIAGEN name; and IMMULINA, a Braun-type lipoproteins, including spirulina extracts and active compounds, which are used to support human immune function. It also offers analytical reference standards and services comprising supply of products to conduct quality control of raw materials and consumer products in dietary supplements, cosmetics, food and beverages, life sciences, and pharmaceutical industries. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. ChromaDex Corporation is headquartered in Los Angeles, California.
Erhalte tagesaktuelle Insights vom finAgent über CHROMADEX CORP

Unternehmensdaten

Name CHROMADEX CORP
Firma ChromaDex Corporation
Symbol CDXC
Website https://www.chromadex.com
Heimatbörse XNCM NASDAQ CAPITAL MARKET
WKN A2AG5N
ISIN US1710774076
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Frank Louis Jaksch Jr.
Marktkapitalisierung 612 Mio
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 0,1 T
Adresse 10900 Wilshire Boulevard, 90024 Los Angeles
IPO Datum 2008-06-25

Aktien-Splits

Datum Split
13.04.2016 1:3

Kennungs-Wechsel

Datum Von Zu
19.03.2025 CDXC NAGE

Ticker Symbole

Name Symbol
Frankfurt OCD1.F
NASDAQ CDXC
NASDAQ NAGE
Weitere Aktien
Investoren, die CHROMADEX CORP halten, haben auch folgende Aktien im Depot:
AMGEN INC
AMGEN INC Aktie
ARIQON WACHSTUM T
ARIQON WACHSTUM T Fonds
AUTODESK INC
AUTODESK INC Aktie
BIOGEN INC
BIOGEN INC Aktie
CISCO SYSTEMS INC
CISCO SYSTEMS INC Aktie
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Aktie
EBAY INC
EBAY INC Aktie
FXS
FXS Crypto
INTEL CORP
INTEL CORP Aktie
MICROSOFT CORP
MICROSOFT CORP Aktie
O'REILLY AUTOMOTIVE INC
O'REILLY AUTOMOTIVE INC Aktie
Revelation Biosciences, Inc. - Common Stock
Revelation Biosciences, Inc. - Common Stock Aktie
The Gabelli Equity Trust Inc. PFD-G
The Gabelli Equity Trust Inc. PFD-G Fonds
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Aktie
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025